113 related articles for article (PubMed ID: 20469988)
1. Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease. Clinical article.
Calviere L; Catalaa I; Marlats F; Viguier A; Bonneville F; Cognard C; Larrue V
J Neurosurg; 2010 Oct; 113(4):753-9. PubMed ID: 20469988
[TBL] [Abstract][Full Text] [Related]
2. Executive dysfunction in adults with moyamoya disease is associated with increased diffusion in frontal white matter.
Calviere L; Ssi Yan Kai G; Catalaa I; Marlats F; Bonneville F; Larrue V
J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):591-3. PubMed ID: 22378919
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H
Roder C; Haas P; Fudali M; Milian M; Ernemann U; Meyer PT; Tatagiba M; Khan N
Neurosurg Rev; 2020 Dec; 43(6):1615-1622. PubMed ID: 31728848
[TBL] [Abstract][Full Text] [Related]
4. Executive function and diffusion in frontal white matter of adults with moyamoya disease.
Nakamizo A; Kikkawa Y; Hiwatashi A; Matsushima T; Sasaki T
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):457-61. PubMed ID: 23608368
[TBL] [Abstract][Full Text] [Related]
5. Different aspects of dysexecutive syndrome in patients with moyamoya disease and its clinical subtypes.
Fang L; Huang J; Zhang Q; Chan RC; Wang R; Wan W
J Neurosurg; 2016 Aug; 125(2):299-307. PubMed ID: 26722860
[TBL] [Abstract][Full Text] [Related]
6. Prolonged Mean Transit Time Detected by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Predicts Cerebrovascular Reserve Impairment in Patients with Moyamoya Disease.
Kawano T; Ohmori Y; Kaku Y; Muta D; Uekawa K; Nakagawa T; Amadatsu T; Kasamo D; Shiraishi S; Kitajima M; Kuratsu J
Cerebrovasc Dis; 2016; 42(1-2):131-8. PubMed ID: 27088711
[TBL] [Abstract][Full Text] [Related]
7. Improvement in cognitive function and cerebral perfusion after bur hole surgery in an adult with moyamoya disease. Case report.
Calviere L; Catalaa I; Marlats F; Januel AC; Lagarrigue J; Larrue V
J Neurosurg; 2011 Aug; 115(2):347-9. PubMed ID: 21529135
[TBL] [Abstract][Full Text] [Related]
8. Postoperative executive function in adult moyamoya disease: a preliminary study of its functional anatomy and behavioral correlates.
Lei Y; Li YJ; Guo QH; Liu XD; Liu Z; Ni W; Su JB; Yang H; Jiang HQ; Xu B; Gu YX; Mao Y
J Neurosurg; 2017 Feb; 126(2):527-536. PubMed ID: 27058195
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of asymptomatic adult moyamoya disease.
Jo KI; Yeon JY; Hong SC; Kim JS
Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
[TBL] [Abstract][Full Text] [Related]
10. Correlation between Clinical Presentations and Hemodynamic Parameters Measured by Dynamic Susceptibility Contrast Magnetic Resonance Imaging in Adult Patients with Moyamoya Disease.
Hirai S; Inaji M; Tanaka Y; Hara S; Nariai T; Maehara T
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2814-2820. PubMed ID: 28778721
[TBL] [Abstract][Full Text] [Related]
11. Which CT perfusion parameter best reflects cerebrovascular reserve?: correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients.
Rim NJ; Kim HS; Shin YS; Kim SY
AJNR Am J Neuroradiol; 2008 Oct; 29(9):1658-63. PubMed ID: 18617583
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive impairment in adults with moyamoya disease without stroke.
Karzmark P; Zeifert PD; Bell-Stephens TE; Steinberg GK; Dorfman LJ
Neurosurgery; 2012 Mar; 70(3):634-8. PubMed ID: 21849919
[TBL] [Abstract][Full Text] [Related]
13. Impact of aberrant cerebral perfusion on resting-state functional MRI: A preliminary investigation of Moyamoya disease.
Wang Y; Wang L; Qiao P; Sheng F; Han C; Ye E; Lei Y; Yan F; Chen S; Zhu Y; Mi G; Li G; Yang Z
PLoS One; 2017; 12(4):e0176461. PubMed ID: 28441445
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography.
Tanaka Y; Nariai T; Nagaoka T; Akimoto H; Ishiwata K; Ishii K; Matsushima Y; Ohno K
J Cereb Blood Flow Metab; 2006 Feb; 26(2):291-300. PubMed ID: 16049427
[TBL] [Abstract][Full Text] [Related]
15. Impairments in brain perfusion, executive control network, topological characteristics, and neurocognition in adult patients with asymptomatic Moyamoya disease.
He S; Liu Z; Wei Y; Duan R; Xu Z; Zhang C; Yuan L; Li T; Ma N; Lou X; Liu X; Wang R
BMC Neurosci; 2021 May; 22(1):35. PubMed ID: 33980154
[TBL] [Abstract][Full Text] [Related]
16. Perfusion characteristics of Moyamoya disease: an anatomically and clinically oriented analysis and comparison.
Schubert GA; Czabanka M; Seiz M; Horn P; Vajkoczy P; Thomé C
Stroke; 2014 Jan; 45(1):101-6. PubMed ID: 24193795
[TBL] [Abstract][Full Text] [Related]
17. A single case report of Moyamoya disease presenting in a psychiatric setting.
Schwarz LR; Thurstin AH; Levine LA
Appl Neuropsychol; 2010 Jan; 17(1):73-7. PubMed ID: 20146125
[TBL] [Abstract][Full Text] [Related]
18. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cognitive function in adult patients with hemorrhagic moyamoya disease who received no surgical revascularization.
Su SH; Hai J; Zhang L; Yu F; Wu YF
Eur J Neurol; 2013 Jul; 20(7):1081-7. PubMed ID: 23577654
[TBL] [Abstract][Full Text] [Related]
20. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
